Last reviewed · How we verify

NCT01776827

Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital

Completed Last updated 5 September 2023
What this trial tests

trial in Gastroesophageal Reflux Disease in 69 participants. Completed in 11 February 2015.

Timeline
22 May 2012
Primary endpoint
1 June 2014
11 February 2015

Quick facts

Lead sponsorUniversity of Nebraska
StatusCompleted
Study typeOBSERVATIONAL
Enrollment69
Start date22 May 2012
Primary completion1 June 2014
Estimated completion11 February 2015
Sites1 location across United States

Conditions studied

Sponsor

University of Nebraska

Who can join

19 and older, any sex, with Gastroesophageal Reflux Disease or Hiatal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gastroesophageal Reflux Disease

Currently open trials in the same condition.

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01776827.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing